X0306 4 2019-01-31 0 0001346302 XERIS PHARMACEUTICALS INC XERS 0001531178 Edick Paul R C/O XERIS PHARMACEUTICALS, INC. 180 N. LASALLE STREET, SUITE 1810 CHICAGO IL 60601 1 1 0 0 See Remarks Common Stock 2019-01-31 4 A 0 125000 0.00 A 125000 D Common Stock 13430 I By: Paul R. Edick 2008 Revocable Trust u/d/t dated 6/25/2018 Stock Option (right to buy) 13.88 2019-01-31 4 A 0 200000 0.00 A 2029-01-31 Common Stock 200000 200000 D These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. 25% of these restricted stock units shall vest on the first anniversary of the vesting commencement date, with the remainder vesting ratably over the following 36 months. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. 25% of these shares shall vest on the first anniversary of the vesting commencement date, with the remainder vesting ratably over the following 36 months. Chairman, President & Chief Executive Officer /s/ Beth Hecht, as Attorney-in-Fact 2019-02-01